CATEGORY B · B-22Intermediate

(S)-22-(Tert-butoxycarbonyl)-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontane-1,41-dioic acid

(S)-22-(叔丁氧羰基)-10,19,24-三氧代-3,6,12,15-四氧杂-9,18,23-三氮杂四十一烷-1,41-二酸
CAS Registry No.
1118767-16-0
Terminal API
Semaglutide
Molecular Weight
846.1
Product Type
Intermediate

Identification & Structure

Chemical structure of (S)-22-(Tert-butoxycarbonyl)-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontane-1,41-dioic acid
2D Structure

CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)C(=O)OC(C)(C)C

Product CodeB-22
Product TypeIntermediate
CAS Number1118767-16-0
Molecular FormulaC43H79N3O13
Molecular Weight846.1
IUPAC Name2-[2-[2-[[2-[2-[2-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[[18-[(2-methylpropan-2-yl)oxy]-18-oxooctadecanoyl]amino]-5-oxopentanoyl]amino]ethoxy]ethoxy]acetyl]amino]ethoxy]ethoxy]acetic acid
SMILESCC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)C(=O)OC(C)(C)C
InChIKeyYZUXNRZPWYRMGH-DHUJRADRSA-N
PubChem CID87275422
Quality ParametersSpecification per batch COA, available on request

Related Terminal API

Listed in our catalog as an intermediate related to Semaglutide. Specification, available documents and lead time are confirmed with the manufacturer for each inquiry.

Direct Inquiries

Request a Quote & Documents

Tell us the quantity, specification and destination. We will reply by email with pricing, lead time and the documents available.

· Email: inquiry@candidpharm.com
· We will reply by email
· Mutual NDA available on request

Documents on Request

  • Batch Certificate of Analysis (COA)
  • Safety Data Sheet (SDS / MSDS)
  • Regulatory documents, subject to manufacturer

Patent Notice

Products listed on this site that are protected by valid patents are not offered for sale in any country where such sale would infringe those patents. Buyers are solely responsible for determining the patent status of any product in their jurisdiction. Where applicable, supply is limited to research purposes or to jurisdictions in which the relevant patents have expired or do not apply.